Q: What is Tecfidera used for?

Tecfidera is used to treat relapsing forms of multiple sclerosis .

Q: What are the active ingredients in Tecfidera?

The active ingredient in Tecfidera is dimethyl fumarate .

Q: What are the side effects of Tecfidera?

Common side effects of Tecfidera may include: flushing diarrhea nausea and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Tecfidera?

Tecfidera belongs to the immunomodulator drug class.

Q: What is the dosage of Tecfidera and how do I take it?

How to Take Tecfidera Tecfidera is taken by mouth, usually twice a day. It is important to swallow the capsules whole. Do not crush, chew, or break the capsule, and do not sprinkle the contents on food, as this can interfere with how the medication is released into your body. Taking with Food You may take this medication with or without food. However, taking Tecfidera with a meal or snack—specifically one high in fat and protein—may help reduce skin flushing, which is a common side effect when starting treatment. Dosing Schedule Treatment typically begins with a lower starting dose for the first several days before increasing to a regular maintenance dose. Follow your healthcare provider's instructions exactly regarding when to increase your dose. Missed Dose If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Q: Is Tecfidera safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Tecfidera in pregnant women. Research in animals has shown that the medication may cause adverse effects on fetal development when administered at doses that also cause toxicity in the mother. Because human data is limited, this medication is generally used during pregnancy only if the potential benefit to the patient justifies the potential risk to the fetus. If you are pregnant or planning to become pregnant, you should inform your healthcare provider to discuss the best way to manage your condition during this time. Breastfeeding It is currently unknown whether Tecfidera passes into human breast milk or how it might affect a nursing infant. Because many medications can be excreted in human milk, caution is advised. You should talk with your doctor about the potential risks and benefits of breastfeeding while taking this medication to determine the safest course of action for you and your baby.

Q: What is the FDA approval status of Tecfidera?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Tecfidera in March 2013. It is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including: Clinically isolated syndrome Relapsing-remitting disease Active secondary progressive disease Safety Communications and Warnings The FDA has issued safety communications regarding the risk of progressive multifocal leukoencephalopathy (PML), a rare and serious brain infection, in patients taking Tecfidera. This risk was identified through postmarketing reports, leading to updates in the drug's labeling. The FDA recommends that healthcare providers monitor patients for signs of PML and perform regular blood tests to check white blood cell counts, as low lymphocyte counts may increase the risk of infection. Additionally, the FDA has monitored potential signals of serious risks through the FDA Adverse Event Reporting System (FAERS), including reports of liver injury and severe hypersensitivity reactions such as angioedema. Regulatory Status Tecfidera is a prescription-only medication and is not classified as a controlled substance. While it does not require a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA-approved labeling includes specific instructions for clinical monitoring, including liver function tests and complete blood counts, to ensure patient safety during therapy.

Question 1

What is Tecfidera?

Accepted Answer

Tecfidera is a medication that contains the active ingredient dimethyl fumarate. It belongs to a class of drugs known as Nrf2 activators, which are thought to help protect the central nervous system from damage.

The medication works by modulating the immune system's response, though the exact way it achieves its effects in the body is not fully understood. It is used as a therapy to help manage multiple sclerosis.

Question 2

What is Tecfidera used for?

Accepted Answer

Tecfidera is used to treat relapsing forms of multiple sclerosis.

Question 3

How does Tecfidera work?

Accepted Answer

The exact way Tecfidera (dimethyl fumarate) works to treat multiple sclerosis (MS) is not fully understood. However, researchers believe it helps manage the condition through two primary methods:

Reducing Inflammation: It is thought to change how the immune system responds, leading to a decrease in the inflammation that attacks the protective covering of nerves.
Protecting Cells: The medication may activate a specific pathway in the body called the Nrf2 pathway. This pathway helps cells defend themselves against oxidative stress, which can cause damage to the brain and spinal cord.

By lowering inflammation and protecting nerve cells, the drug helps reduce the frequency of MS relapses and may slow the progression of physical disability associated with the disease.

Question 4

What are the active ingredients in Tecfidera?

Accepted Answer

The active ingredient in Tecfidera is dimethyl fumarate.

Question 5

What are the side effects of Tecfidera?

Accepted Answer

Common side effects of Tecfidera may include:

flushing
diarrhea
nausea
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Tecfidera?

Accepted Answer

Tecfidera belongs to the immunomodulator drug class.

Question 7

What is the dosage of Tecfidera and how do I take it?

Accepted Answer

How to Take Tecfidera

Tecfidera is taken by mouth, usually twice a day. It is important to swallow the capsules whole. Do not crush, chew, or break the capsule, and do not sprinkle the contents on food, as this can interfere with how the medication is released into your body.

Taking with Food

You may take this medication with or without food. However, taking Tecfidera with a meal or snack—specifically one high in fat and protein—may help reduce skin flushing, which is a common side effect when starting treatment.

Dosing Schedule

Treatment typically begins with a lower starting dose for the first several days before increasing to a regular maintenance dose. Follow your healthcare provider's instructions exactly regarding when to increase your dose.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Question 8

Is Tecfidera safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Tecfidera in pregnant women. Research in animals has shown that the medication may cause adverse effects on fetal development when administered at doses that also cause toxicity in the mother. Because human data is limited, this medication is generally used during pregnancy only if the potential benefit to the patient justifies the potential risk to the fetus.

If you are pregnant or planning to become pregnant, you should inform your healthcare provider to discuss the best way to manage your condition during this time.

Breastfeeding

It is currently unknown whether Tecfidera passes into human breast milk or how it might affect a nursing infant. Because many medications can be excreted in human milk, caution is advised. You should talk with your doctor about the potential risks and benefits of breastfeeding while taking this medication to determine the safest course of action for you and your baby.

Question 9

What forms and strengths does Tecfidera come in?

Accepted Answer

Tecfidera is supplied as delayed-release capsules for oral administration. These capsules are designed to release the medication after they pass through the stomach to help with absorption and manage how the drug enters the system.

Delayed-release capsules

The capsules must be swallowed whole and intact. They should not be crushed, chewed, or broken, and the contents should not be sprinkled on food, as this can interfere with the delayed-release properties of the medication.

Question 10

What is the FDA approval status of Tecfidera?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Tecfidera in March 2013. It is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including:

Clinically isolated syndrome
Relapsing-remitting disease
Active secondary progressive disease

Safety Communications and Warnings

The FDA has issued safety communications regarding the risk of progressive multifocal leukoencephalopathy (PML), a rare and serious brain infection, in patients taking Tecfidera. This risk was identified through postmarketing reports, leading to updates in the drug's labeling. The FDA recommends that healthcare providers monitor patients for signs of PML and perform regular blood tests to check white blood cell counts, as low lymphocyte counts may increase the risk of infection.

Additionally, the FDA has monitored potential signals of serious risks through the FDA Adverse Event Reporting System (FAERS), including reports of liver injury and severe hypersensitivity reactions such as angioedema.

Regulatory Status

Tecfidera is a prescription-only medication and is not classified as a controlled substance. While it does not require a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA-approved labeling includes specific instructions for clinical monitoring, including liver function tests and complete blood counts, to ensure patient safety during therapy.

Question 11

What should I know about Tecfidera and cost?

Accepted Answer

Brand vs.

Generic

Tecfidera is the brand name for the drug dimethyl fumarate. Generic versions of this medication are available and are generally more affordable than the brand-name product. Your healthcare provider or pharmacist can help determine if the generic version is appropriate for your treatment plan.

Insurance and Pharmacy Factors

Most insurance plans, including Medicare and private health insurance, cover dimethyl fumarate. However, the amount you pay out-of-pocket will depend on your specific plan's formulary, deductible, and copay requirements. Because Tecfidera is used to treat a chronic condition like multiple sclerosis, it is often classified as a specialty drug and may need to be filled through a specialty pharmacy rather than a standard retail pharmacy.

Financial Assistance Programs

There are several ways to potentially lower the cost of this medication:

Copay Cards: The manufacturer may offer copay savings cards for patients with commercial insurance to help lower monthly out-of-pocket costs.
Patient Assistance: Programs may be available for individuals who are uninsured or underinsured to help them access their medication at a lower cost or for free.
Support Services: Many manufacturers provide dedicated support services to help patients navigate insurance approvals and find financial resources to cover their treatment.

Tecfidera

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Tecfidera

Hospitals.net Disclosure